PROFOCAL RX

FOCAL LASER THERAPY FOR PROSTATE CANCER

(ProFocal-Rx is not available and undergoing global clinical investigation)

One in 6 men will be diagnosed with Prostate Cancer in their lifetime. Curative treatment will be recommended in 2 out of 3 men. The current options available are either surgery or radiotherapy. Surgery and radiotherapy are curative but are often associated with significant morbidity impacting the quality of life of the individual.

Focal Therapy only targets the prostate lesions that can be seen on MRI scan. The option of surgery or radiotherapy is always possible after Focal Therapy and treatment is repeatable if necessary. With Focal Therapy you are not limited to a single treatment option, it opens up more choices for patients.

ProFocal-Rx LASER delivery system is a dual component precision surgical tool. It is designed by Surgeons for Surgeons to target and destroy specific lesions.